Literature DB >> 6889217

The effect of nifedipine on arterial pressure and reflex cardiac control.

W A Littler, T J Stallard, R D Watson, R A McLeay.   

Abstract

Nine patients with untreated, essential hypertension (mean casual blood pressure 173/109 +/- 14/7 mmHg (+/- s.d.] were studied in the control state and then following 16 weeks treatment with nifedipine 10 mg orally 8 hourly. Direct arterial blood pressure was monitored continuously over 24 hours and demonstrated that nifedipine significantly reduced systolic and diastolic blood pressure throughout the day and the night. The variability of blood pressure was not altered by nifedipine therapy. There was no significant change in heart rate after nifedipine therapy. At each study the sensitivity and setting of the baroreflex response to intravenous phenylephrine was measured. Following chronic nifedipine therapy there was re-setting of the sino-aortic baroreflex and an increase in its sensitivity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6889217

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 2.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

3.  The pharmacodynamics and pharmacokinetics of a new calcium antagonist nisoldipine in normotensive and hypertensive subjects.

Authors:  F Pasanisi; P A Meredith; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  Effects of nifedipine versus hydralazine on sympathetic activity and cardiac function in patients with hypertension persisting on diuretic plus beta-blocker therapy.

Authors:  F H Leenen; R J Burns; M G Myers; D Frankel
Journal:  Cardiovasc Drugs Ther       Date:  1990-04       Impact factor: 3.727

5.  Comparison of the efficacy of nicardipine, a new calcium channel blocker, with nifedipine in the treatment of mild to moderate essential hypertension.

Authors:  C Armstrong; J Garnham; R Blackwood
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

6.  The Antihypertensive Drug Nifedipine Modulates the Metabolism of Chondrocytes and Human Bone Marrow-Derived Mesenchymal Stem Cells.

Authors:  Ilona Uzieliene; Eiva Bernotiene; Greta Rakauskiene; Jaroslav Denkovskij; Edvardas Bagdonas; Zygmunt Mackiewicz; Narunas Porvaneckas; Giedrius Kvederas; Ali Mobasheri
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.